SLC20A2, solute carrier family 20 member 2, 6575

N. diseases: 104; N. variants: 36
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Idiopathic basal ganglia calcification 1
0.760 Biomarker disease GENOMICS_ENGLAND Primary familial brain calcification linked to deletion of 5' noncoding region of SLC20A2. 27726124 2017
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease BEFREE Our data confirm that mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. 25958344 2015
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Evaluation of SLC20A2 mutations that cause idiopathic basal ganglia calcification in Japan. 24463626 2014
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Primary familial brain calcification: Genetic analysis and clinical spectrum. 25284758 2014
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Phenotypic spectrum of probable and genetically-confirmed idiopathic basal ganglia calcification. 24065723 2013
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease BEFREE Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. 23334463 2013
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. 23334463 2013
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Novel SLC20A2 mutations identified in southern Chinese patients with idiopathic basal ganglia calcification. 23939468 2013
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification. 23406454 2013
Idiopathic basal ganglia calcification 1
0.760 AlteredExpression disease BEFREE We propose that the regional expression pattern of SLC20A1 and SLC20A2 might explain the unique calcification pattern observed in FIBGC patients. 23437308 2013
Idiopathic basal ganglia calcification 1
0.760 AlteredExpression disease BEFREE Microarray analysis provided evidence that the neuroanatomical pattern of expression for SLC20A2 is highest in the regions most commonly affected in FIBGC. 23576097 2013
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease BEFREE Using a different technique, that is linkage analysis, mutations in EIF4G1 were implicated as a cause of Parkinson disease and mutations in SLC20A2 as a cause of familial idiopathic basal ganglia calcification. 22772876 2012
Idiopathic basal ganglia calcification 1
0.760 Biomarker disease CTD_human Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. 22327515 2012
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease BEFREE Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. 22327515 2012
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. 22327515 2012
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease CLINVAR Mutations in SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. 22327515 2012
Idiopathic basal ganglia calcification 1
0.760 GeneticVariation disease UNIPROT Evolutionary and experimental analyses of inorganic phosphate transporter PiT family reveals two related signature sequences harboring highly conserved aspartic acids critical for sodium-dependent phosphate transport function of human PiT2. 15955065 2005
Idiopathic basal ganglia calcification 1
0.760 Biomarker disease GENOMICS_ENGLAND
Idiopathic basal ganglia calcification 1
0.760 CausalMutation disease CLINVAR
Idiopathic basal ganglia calcification 1
0.760 Biomarker disease GENOMICS_ENGLAND
CUI: C0393590
Disease: Fahr's syndrome (disorder)
Fahr's syndrome (disorder)
0.730 GeneticVariation disease BEFREE We have identified a novel SLC20A2 mutation in a family with Fahr's disease. 30776674 2019
CUI: C0393590
Disease: Fahr's syndrome (disorder)
Fahr's syndrome (disorder)
0.730 Biomarker disease GENOMICS_ENGLAND Primary familial brain calcification linked to deletion of 5' noncoding region of SLC20A2. 27726124 2017
CUI: C0393590
Disease: Fahr's syndrome (disorder)
Fahr's syndrome (disorder)
0.730 Biomarker disease MGD Mutations in the SLC20A2-gene encoding the inorganic phosphate (Pi) transporter PiT2 can explain approximately 40% of the familial cases of the rare neurodegenerative disorder primary familial brain calcification (Fahr's disease). 26660102 2016
CUI: C0393590
Disease: Fahr's syndrome (disorder)
Fahr's syndrome (disorder)
0.730 AlteredExpression disease BEFREE It also suggests that vitamin D might be used to regulate SLC20A2 gene expression, as well as reduce brain calcification which occurs in Fahr's disease and normal aging. 27184385 2016
CUI: C0393590
Disease: Fahr's syndrome (disorder)
Fahr's syndrome (disorder)
0.730 GeneticVariation disease BEFREE Fahr's disease linked to a novel SLC20A2 gene mutation manifesting with dynamic aphasia. 25348593 2014